Etid klinik pou Fatig nan Washington
7 etid pou Fatig ap chèche patisipan nan sit nan Washington.
Vil nan Washington
Tèks ofisyèl etid la (Anglè)
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- Arthritis Northwest PLLC, Spokane
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07621809A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Virginia Mason Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center, Seattle
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06989437A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
- Washington State University Sleep and Performance Center, Spokane
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07500090A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
- Sleep and Performance Research Center, Spokane
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT07675135Factorial Optimization Trial to Test Cognitive Behavioral Therapy Components for Multiple Sclerosis Fatigue
- Multiple Sclerosis Center at UW Medical Center - Northwest, Seattle
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Mar 16, 2026 · NCT06809192Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
- Seattle Children's Hospital, Seattle
Ap rekrite
Laj 12 a 22 · Tout sèks · Mizajou Oct 30, 2025 · NCT06232304Increasing Physical Activity for Adults With Multiple Sclerosis (MS)
- UW Medicine, Seattle
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Feb 22, 2024 · NCT06270641Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.